Literature DB >> 26416862

Cell Wall Recycling-Linked Coregulation of AmpC and PenB β-Lactamases through ampD Mutations in Burkholderia cenocepacia.

Junghyun Hwang1, Heenam Stanley Kim2.   

Abstract

In many Gram-negative pathogens, mutations in the key cell wall-recycling enzyme AmpD (N-acetyl-anhydromuramyl-L-alanine amidase) affect the activity of the regulator AmpR, which leads to the expression of AmpC β-lactamase, conferring resistance to expanded-spectrum cephalosporin antibiotics. Burkholderia cepacia complex (Bcc) species also have these Amp homologs; however, the regulatory circuitry and the nature of causal ampD mutations remain to be explored. A total of 92 ampD mutants were obtained, representing four types of mutations: single nucleotide substitution (causing an amino acid substitution or antitermination of the enzyme), duplication, deletion, and IS element insertion. Duplication, which can go through reversion, was the most frequent type. Intriguingly, mutations in ampD led to the induction of two β-lactamases, AmpC and PenB. Coregulation of AmpC and PenB in B. cenocepacia, and likely also in many Bcc species with the same gene organization, poses a serious threat to human health. This resistance mechanism is of evolutionary optimization in that ampD is highly prone to mutations allowing rapid response to antibiotic challenge, and many of the mutations are reversible in order to resume cell wall recycling when the antibiotic challenge is relieved.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26416862      PMCID: PMC4649219          DOI: 10.1128/AAC.01068-15

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  43 in total

Review 1.  A decade of Burkholderia cenocepacia virulence determinant research.

Authors:  Slade A Loutet; Miguel A Valvano
Journal:  Infect Immun       Date:  2010-07-19       Impact factor: 3.441

2.  An outbreak of Burkholderia cenocepacia bacteremia in immunocompromised oncology patients.

Authors:  T Mann; D Ben-David; A Zlotkin; D Shachar; N Keller; A Toren; A Nagler; G Smollan; A Barzilai; G Rahav
Journal:  Infection       Date:  2010-04-01       Impact factor: 3.553

3.  Crystal structures of bacterial peptidoglycan amidase AmpD and an unprecedented activation mechanism.

Authors:  Cesar Carrasco-López; Alzoray Rojas-Altuve; Weilie Zhang; Dusan Hesek; Mijoon Lee; Sophie Barbe; Isabelle André; Pilar Ferrer; Noella Silva-Martin; German R Castro; Martín Martínez-Ripoll; Shahriar Mobashery; Juan A Hermoso
Journal:  J Biol Chem       Date:  2011-07-20       Impact factor: 5.157

4.  Unipro UGENE: a unified bioinformatics toolkit.

Authors:  Konstantin Okonechnikov; Olga Golosova; Mikhail Fursov
Journal:  Bioinformatics       Date:  2012-02-24       Impact factor: 6.937

Review 5.  Burkholderia cenocepacia in cystic fibrosis: epidemiology and molecular mechanisms of virulence.

Authors:  P Drevinek; E Mahenthiralingam
Journal:  Clin Microbiol Infect       Date:  2010-07       Impact factor: 8.067

6.  Naturally occurring Class A ss-lactamases from the Burkholderia cepacia complex.

Authors:  Laurent Poirel; José-Manuel Rodriguez-Martinez; Patrick Plésiat; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2008-12-15       Impact factor: 5.191

7.  The early stage of bacterial genome-reductive evolution in the host.

Authors:  Han Song; Junghyun Hwang; Hyojeong Yi; Ricky L Ulrich; Yan Yu; William C Nierman; Heenam Stanley Kim
Journal:  PLoS Pathog       Date:  2010-05-27       Impact factor: 6.823

8.  Variation of the antimicrobial susceptibility profiles of Burkholderia cepacia complex clonal isolates obtained from chronically infected cystic fibrosis patients: a five-year survey in the major Portuguese treatment center.

Authors:  J H Leitão; S A Sousa; M V Cunha; M J Salgado; J Melo-Cristino; M C Barreto; I Sá-Correia
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-07-04       Impact factor: 3.267

9.  Spontaneous and evolutionary changes in the antibiotic resistance of Burkholderia cenocepacia observed by global gene expression analysis.

Authors:  Andrea Sass; Angela Marchbank; Elizabeth Tullis; John J Lipuma; Eshwar Mahenthiralingam
Journal:  BMC Genomics       Date:  2011-07-22       Impact factor: 3.969

10.  Twelve positions in a β-lactamase that can expand its substrate spectrum with a single amino acid substitution.

Authors:  Hyojeong Yi; Kwang-Hwi Cho; Yun Sung Cho; Karan Kim; William C Nierman; Heenam Stanley Kim
Journal:  PLoS One       Date:  2012-05-22       Impact factor: 3.240

View more
  12 in total

Review 1.  Therapies for multidrug resistant and extensively drug-resistant non-fermenting gram-negative bacteria causing nosocomial infections: a perilous journey toward 'molecularly targeted' therapy.

Authors:  Nadim G El Chakhtoura; Elie Saade; Alina Iovleva; Mohamad Yasmin; Brigid Wilson; Federico Perez; Robert A Bonomo
Journal:  Expert Rev Anti Infect Ther       Date:  2018-01-16       Impact factor: 5.091

2.  In Vitro Susceptibility of Burkholderia cepacia Complex Isolated from Cystic Fibrosis Patients to Ceftazidime-Avibactam and Ceftolozane-Tazobactam.

Authors:  A Van Dalem; M Herpol; F Echahidi; C Peeters; I Wybo; E De Wachter; P Vandamme; D Piérard
Journal:  Antimicrob Agents Chemother       Date:  2018-08-27       Impact factor: 5.191

Review 3.  Antibiotic resistance in Burkholderia species.

Authors:  Katherine A Rhodes; Herbert P Schweizer
Journal:  Drug Resist Updat       Date:  2016-07-30       Impact factor: 18.500

4.  Evaluation of Antimicrobial Susceptibility Testing Methods for Burkholderia cenocepacia and Burkholderia multivorans Isolates from Cystic Fibrosis Patients.

Authors:  Holly K Huse; Mark J Lee; Mandy Wootton; Susan E Sharp; Maria Traczewski; John J LiPuma; Peter Jorth
Journal:  J Clin Microbiol       Date:  2021-09-15       Impact factor: 5.948

5.  Effect of β-Lactamase inhibitors on in vitro activity of β-Lactam antibiotics against Burkholderia cepacia complex species.

Authors:  Annelien Everaert; Tom Coenye
Journal:  Antimicrob Resist Infect Control       Date:  2016-11-16       Impact factor: 4.887

Review 6.  Burkholderia cenocepacia Infections in Cystic Fibrosis Patients: Drug Resistance and Therapeutic Approaches.

Authors:  Viola C Scoffone; Laurent R Chiarelli; Gabriele Trespidi; Massimo Mentasti; Giovanna Riccardi; Silvia Buroni
Journal:  Front Microbiol       Date:  2017-08-22       Impact factor: 5.640

7.  A genome-wide association analysis reveals a potential role for recombination in the evolution of antimicrobial resistance in Burkholderia multivorans.

Authors:  Julio Diaz Caballero; Shawn T Clark; Pauline W Wang; Sylva L Donaldson; Bryan Coburn; D Elizabeth Tullis; Yvonne C W Yau; Valerie J Waters; David M Hwang; David S Guttman
Journal:  PLoS Pathog       Date:  2018-12-07       Impact factor: 6.823

Review 8.  Accurate identification and epidemiological characterization of Burkholderia cepacia complex: an update.

Authors:  Naveen Kumar Devanga Ragupathi; Balaji Veeraraghavan
Journal:  Ann Clin Microbiol Antimicrob       Date:  2019-02-04       Impact factor: 3.944

9.  Molecular and epidemiological analysis of a Burkholderia cepacia sepsis outbreak from a tertiary care hospital in Bangladesh.

Authors:  Refath Farzana; Lim S Jones; Md Anisur Rahman; Kirsty Sands; Edward Portal; Ian Boostrom; Md Abul Kalam; Brekhna Hasan; Afifah Khan; Timothy R Walsh
Journal:  PLoS Negl Trop Dis       Date:  2020-04-09

10.  Competitive Fitness of Essential Gene Knockdowns Reveals a Broad-Spectrum Antibacterial Inhibitor of the Cell Division Protein FtsZ.

Authors:  Andrew M Hogan; Viola C Scoffone; Vadim Makarov; April S Gislason; Haben Tesfu; Maria S Stietz; Ann Karen C Brassinga; Michael Domaratzki; Xuan Li; Alberto Azzalin; Marco Biggiogera; Olga Riabova; Natalia Monakhova; Laurent R Chiarelli; Giovanna Riccardi; Silvia Buroni; Silvia T Cardona
Journal:  Antimicrob Agents Chemother       Date:  2018-11-26       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.